Pretreated baseline neutrophil count and chemotherapy‐induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1445-5994|45|8|854-859

ISSN： 1444-0903

Source： INTERNAL MEDICINE JOURNAL, Vol.45, Iss.8, 2015-08, pp. : 854-859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Novel Scoring System Based on Fibrinogen and the Neutrophil-Lymphocyte Ratio as a Predictor of Chemotherapy Response and Prognosis in Patients with Advanced Gastric Cancer

By  

Oncology, Vol. 90, Iss. 4, 2016-03 ,pp. : 186-192

Karger

Access to resources Recommend Favorite

Evaluation of Systemic Inflammatory Response Biomarkers in Patients Receiving Chemotherapy for Unresectable and Recurrent Advanced Gastric Cancer

By  

Oncology, Vol. 90, Iss. 6, 2016-05 ,pp. : 321-326

Karger

Access to resources Recommend Favorite

Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells

By Kopjar N.   Milas I.   Garaj-Vrhovac V.   Gamulin M.  

Clinical and Experimental Medicine, Vol. 6, Iss. 4, 2006-12 ,pp. : 177-190

Springer Publishing Company

Access to resources Recommend Favorite

Pegfilgrastim – Rational Drug Design for the Management of Chemotherapy-Induced Neutropenia

By  

Oncology Research and Treatment, Vol. 28, Iss. 11, 2005-10 ,pp. : 595-602

Karger

Access to resources Recommend Favorite

Inflammation-Based Prognostic Score Predicts Survival in Patients with Advanced Gastric Cancer Receiving Biweekly Docetaxel and S-1 Combination Chemotherapy

By  

Oncology, Vol. 83, Iss. 4, 2012-08 ,pp. : 183-191

Karger

Access to resources Recommend Favorite